HPLC法对比不同产地南板蓝根药材靛蓝、靛玉红含量的研究

目的:以高效液相色谱法对广东不同产地(广东高要、广东罗定、广东罗浮、广东鼎湖)南板蓝根药材及常用伪品(爵床科植物广西马蓝)的主要成分靛蓝、靛玉红进行含量测定,对比不同产地南板蓝根药材靛蓝、靛玉红含量的差别.方法:采用HPLC法建立南板蓝根药材中靛蓝与靛玉红的含量测定方法.色谱条件:Kromasil C18(4.6mm×250mm,5μm);以甲醇-水(75:25)为流动相;检测波长:290nm;流速:1.0ml/min.柱温:40℃.结果:①靛玉红、靛蓝线性范围分别为1.652～33.04μg/ml、1.284～25.68μg/ml.回收率分别为98.92%,RSD=1.52%,N=5(靛玉红);102.61%,RSD=1.28%,N=5(靛蓝);②广西马蓝中未检测出靛玉红、靛蓝.结论:该方法操作简便、准确快速、重现性好,可完善现行的南板蓝根的药材质量标准,有效控制南板蓝根药材的质量.     

根部淹水对菘蓝活性成分的影响

对菘蓝幼苗根系进行不同深度的淹水处理,采用HPLC法测定不同处理下菘蓝叶中靛蓝、靛玉红的含量。结果表明,淹水处理初期样品与对照相比,靛蓝的含量呈上升趋势,淹水后期急剧下降;靛玉红含量在淹水第1d急剧上升,之后随淹水时间延长不断降低。淹水深度越深对靛蓝、靛玉红含量影响越大。适当的淹水处理能诱导菘蓝叶中次生代谢产物靛蓝、靛玉红的合成与积累。该结果可为栽培菘蓝的质量控制和有效利用提供理论依据。     

靛玉红治疗慢性粒细胞白血病作用原理的研究

 靛玉红是一种新型抗癌药物,治疗慢性粒细胞白血病(CML)有较好的疗效。本文通过体内及体外实验采用靛玉红—脂质体为剂型,观察药物对CML细胞的作用。据荧光偏振度的测定结果表明,此药物分子能降低大白鼠白细胞膜流动性。还测定服药3天的患者外周白细胞中DNA聚合酶Ⅰ的活性,比治疗前降低74±1％。为靛玉红抑制CML细胞DNA合成的机理提供依据。此外,还使用载有靛玉红的脂质体进行体外实验,表明靛玉红可以直接降低细胞膜的流动性以及抑制CML细胞中DNA聚合酶Ⅰ活性。对靛玉红治疗CML的作用机理提出一些看法和讨论。     

冻伤蓝变对广义虾脊兰属植物中4种吲哚基衍生物含量的影响

以6种广义虾脊兰属植物和2种树兰亚科植物为材料,利用液相色谱 串联三重四极杆质谱仪(LCMS QQQ)测定了冻伤处理前后花和叶片中靛苷、靛红、靛蓝和靛玉红4种吲哚基衍生物的含量,分析广义虾脊兰属植物吲哚基衍生物的生成及种属间含量的差异。结果显示：(1)4种吲哚基衍生物在所测定的6种广义虾脊兰属植物中均被检出,但在2种树兰亚科植物五唇兰和足茎毛兰中均未被发现。(2)在所测定的6种广义虾脊兰属植物花和叶片中,冻伤处理后的靛蓝、靛玉红和靛红含量均显著上升,而靛苷含量显著下降,同时花中的吲哚基衍生物含量均高于叶片。(3)6种广义虾脊兰属植物花和叶中吲哚基衍生物总含量以黄兰花最高,三褶虾脊兰叶最低。研究表明,冻伤处理引起靛苷向靛蓝的大量转化是导致冻伤后广义虾脊兰属植物组织中呈现出蓝色的主要原因,推测吲哚基衍生物可能也是一类与植物防御相关的化合物,在植物抵御逆境中扮演着重要的角色。     

壳聚糖-海藻酸钠靛玉红自微乳缓释微囊制备、评价及体外释放的研究

以靛玉红自微乳为囊心物,壳聚糖和海藻酸钠为囊材,采用复凝聚法制备壳聚糖-海藻酸钠靛玉红自乳化缓释微囊,通过正交实验和单因素考察确定壳聚糖-海藻酸钠靛玉红缓释微囊的最佳制备工艺。并以载药量、包封率为评价指标对其进行质量评价,同时以体外释放度评价其释药性能。壳聚糖-海藻酸钠靛玉红缓释微囊的最佳工艺是海藻酸钠的浓度为1.5%,靛玉红自微乳体积、海藻酸钠体积、壳聚糖质量三者比例为1∶1∶0.5,氯化钙浓度的最佳浓度为2.0%。采用该工艺制备的微囊载药量为0.0416%、包封率为79.2%,体外释放24 h累积释放率为(97.1±2.68)%。该微囊的释放符合Higuchi方程和一级释药模型,具有较好的缓释作用。     

板蓝根中靛玉红提取方法研究

采用薄层色谱分析比较了水煎法和渗漉法对板蓝根有效成分--靛玉红的提取效果,并对以前的提取方法做了改进,提高了靛玉红的提取效率。     

HPLC测定板蓝根中靛玉红含量的方法

目的:建立板蓝根中靛玉红含量测定方法.方法:用HPLC法,色谱柱:Shim-packCLC-ODS(150 mm×6mm),流动相:甲醇:氯仿(80:20)(0.1%二乙氨,用醋酸调中性),流速:1 mL/min,检测波长:290 nm,柱温:24℃.结果:靛玉红在1.058～16.928 μg/mL的浓度范围内具有良好的线性关系(r=0.999 98),精密度RSD=1.02%,加样回收率为96.87%,重现性RSD=0.94%.结论:本法简单可行,准确性好,重现性高,是板蓝根中靛玉红含量测定的有效方法.     

组合蛋白质工程和代谢工程设计全细胞催化剂合成靛蓝和靛玉红

从嗜高温放线菌Thermobifida fusca中分离得到的苯基丙酮单加氧酶主要催化芳香族化合物的Baeyer-Villiger氧化反应。对该酶的结构和功能进行研究时,发现位于底物结合口袋的Met446位点突变可以赋予突变酶催化C-H键活化的新功能,氧化吲哚合成靛蓝和靛玉红,但产量仅为1.89 mg/L。为了获得合成靛蓝和靛玉红的全细胞催化剂,直接补加吲哚并不能提高细胞合成效率,补加吲哚的前体物质L-色氨酸可以使细胞合成靛蓝和靛玉红的能力提高4.5倍,达到8.43 mg/L。为了进一步提高细胞的生物合成效率,通过代谢工程改造大肠杆菌的糖代谢途径,阻断葡萄糖异构酶基因pgi,使磷酸戊糖途径代替糖酵解途径成为葡萄糖的主要代谢通路,从而为细胞提供更多氧化吲哚所需的辅因子NADPH,导致细胞合成靛蓝和靛玉红的效率进一步提高3倍,达到25 mg/L。通过组合蛋白质工程和代谢工程设计全细胞催化剂不仅可以高效地合成靛蓝和靛玉红,而且设计理念为相关全细胞催化剂的开发提供了一种新的策略。     

靛玉红、蛇床子素抗外阴阴道念珠菌病混合菌生物膜作用的研究

目的研究中药有效成分靛玉红、蛇床子素抗外阴阴道念珠菌病混合菌生物膜的作用。方法体外建立白念珠菌（Candidaalbicans）铜绿假单胞菌（Pseudomonasaeruginosa,P．a）混合菌生物膜（Biofilm,BF）,XTT减低法及形态学观察白念珠菌混合茵生物膜的形成过程;形态学观察、活菌计数法评价中药有效成分靛玉红（indirubin）、蛇床子素（Ostho）对白念珠菌混合菌生物膜的最小抑膜浓度（SMIC）,并经扫描电镜确认。结果白念珠菌混合菌48h能形成成熟的生物膜;62．5mg／L浓度的靛玉红能抑制白念珠菌混合菌生物膜的形成。500mg／L浓度的蛇床子素未见有抑制白念珠菌混合菌生物膜的作用。结论靛玉红由于具有抗生物膜的作用,可用于预防外阴阴道念珠菌病的复发。     

我国蓝草的传统植物学知识研究

蓝草在我国历史上曾是重要的经济作物,蓝草制备的植物靛蓝具有抗菌消炎和抗紫外线等保健作用,然而在合成靛蓝商业化的冲击下,蓝草制靛技艺几乎消亡。近年来,伴随着人们对环保和生物多样性的关注,植物靛蓝需求量不断增加,对蓝草的研究也越来越受关注。该文在文献研究的基础上,简要介绍了我国民间利用的蓝草种类及分布,对我国蓝草制靛工艺的发展进行了梳理,重点阐述了制靛工艺原理和工艺传承现状,并对存在的问题进行了讨论。结果表明:文献记载的我国蓝草共10种及变种,分属于6科6属,现利用的蓝草仅5种;我国蓝草制靛工艺从浸揉染色法发展为固态发酵制蓝法和液态发酵制靛法,只有液态发酵制靛法沿用至今;制靛工艺是将蓝草中的前体物质转化为靛蓝并伴有靛玉红等副产物生成的过程,影响靛蓝纯度的因素包括蓝草的材料选择、温度、浸泡时间、pH值、溶氧量等。目前我国蓝草的研究已取得了一些成果,但在蓝草种类的古籍考证、蓝草种质资源的挖掘以及蓝草传统制靛工艺的还原和再现等方面仍有待于进一步研究。     

Assignment of gene coding for cell surface glycoprotein with a molecular weight of 75,000 to human chromosome 11

The gene for a cell surface glycoprotein recognized by a mouse monoclonal antibody (Mab 4), has been assigned to human chromosome 11 by the study of mouse-human lymphocyte hybrids. The antigen is present on all human peripheral blood leukocytes, on human fibroblasts, and on human lymphoid and erythroid cell lines, but not on erythrocytes. Immunoprecipitation and polyacrylamide slab gel electrophoresis of both human cells and mouse-human hybrid clones carrying human chromosome 11 show that the apparent molecular weight of this glycoprotein is 75,000.     

The ethics of ex utero research on spare 'non-viable' IVF human embryos

In this paper, the focus is not on some particular developmental feature of the human embryo, but rather on the embryo's potential for development tout court. To this end, the moral relevance of the difference between human embryos that have the potential for continued human growth and development and human embryos that do not have this potential is explored and a distinction between viable and non-viable IVF human embryos is introduced. This is followed by a discussion of what is morally wrong with killing to show that none of the concerns associated with the act of killing apply to the destruction of non-viable IVF human embryos. On this basis, it is argued that scientifically and ethically sound research on spare non-viable IVF human embryos may proceed.     

人B细胞永生化研究进展

人源单克隆抗体具有免疫原性低、半衰期长等优势,成为了体内应用中不可或缺的生物制剂.人类抗体库为人源单克隆抗体的制备提供了丰富的来源,人B细胞永生化是获得人类抗体库的潜在有效方法,可应用于人源单克隆抗体的制备.由于各平台均有亟待解决的问题,基于人B细胞永生化的抗体制备尚局限在实验室研究阶段,且目前尚缺乏一篇系统综述以明确...     

The human embryo: a scientist's point of view

...Thus, my judgement is that a human embryo is not a human person, and so we may do experiments on it which involve killing it. But my judgement is also that a human embryo has the potential to become a human being. The consequence of this attribute is that it imposes limits on the kinds of experiments which may be performed on human embryos. It is this which sets the boundaries. Experiments which may harm the embryo while still allowing it subsequently to realise its potential, and become a person, should not be permitted. It is the potentiality of the human embryo which governs our behaviour towards it. Its potential makes it special, and radically different from any other human tissue. This potential which the early embryo has means that great respect must always be accorded it, and great thought and care must surround any dealings with it....     

HUMAN NATURE AND ENHANCEMENT

Appeals to the idea of human nature are frequent in the voluminous literature on the ethics of enhancing human beings through biotechnology. Two chief concerns about the impact of enhancements on human nature have been voiced. The first is that enhancement may alter or destroy human nature. The second is that if enhancement alters or destroys human nature, this will undercut our ability to ascertain the good because, for us, the good is determined by our nature. The first concern assumes that altering or destroying human nature is in itself a bad thing. The second concern assumes that human nature provides a standard without which we cannot make coherent, defensible judgments about what is good.
I will argue (1) that there is nothing wrong, per se, with altering or destroying human nature, because, on a plausible understanding of what human nature is, it contains bad as well as good characteristics and there is no reason to believe that eliminating some of the bad would so imperil the good as to make the elimination of the bad impermissible, and (2) that altering or destroying human nature need not result in the loss of our ability to make judgments about the good, because we possess a conception of the good by which we can and do evaluate human nature. I will argue that appeals to human nature tend to obscure rather than illuminate the debate over the ethics of enhancement and can be eliminated in favor of more cogent considerations.     

生态环境保护与福祉

结合能力框架探讨了福祉的内涵,界定了生态系统服务及其功能对人类福祉的内涵,指人类在生态系统生产和利用中的自由选择和能力,而贫穷指能力和发展的受限即福祉的下降.生态系统的退化和破坏将严重威胁人类福祉(尤其是穷人的福祉),生物多样性作为生态系统的核心,生物多样性的保护将促进生态系统服务的保护,进而提高人类福祉.关注强烈依赖于生态系统服务的贫困人群的福祉,并科学有效地实施生态补偿将可能实现生态保护和人类福祉改善的双赢.     

The human post‐fertile lifespan in comparative evolutionary context

There persist two widely held but mutually inconsistent views on the evolution of post‐fertile lifespan of human females. The first, prevalent within anthropology, sees post‐fertile lifespan (PFLS) in the light of adaptive processes, focusing on the social and economic habits of humans that selected for a lengthy PFLS. 1 - 3 This view rests on the assumption that human PFLS is distinct from that of other species, and focuses on quantifying the selective causes and consequences of that difference. The second view, prevalent within gerontology and comparative biology, emphasizes that PFLS is a phylogenetically widespread trait 4 - 6 or that human PFLS is predictable based on life‐history allometries. 7 In this view, human PFLS is part of a broad cross‐species pattern and its genesis cannot, therefore, rely on human‐specific traits. Those who advocate the second view have questioned the “special pleading” for human specific explanations of PFLS, 4 and have argued that human PFLS is quantitatively greater but not qualitatively different than PFLS in many other animals. 5 , 8 Papers asking whether human PFLS is explained by the importance of mothers more than grandmothers, whether paternal or maternal grandparents have more of an effect on child survival, or who is providing the excess calories are associated with the first view that assumes the need to explain the existence of human PFLS on the basis of a uniquely human socioecology. Anthropologists largely see human PFLS as derived, while comparative gerontologists point to evidence that it is one instance of a ubiquitous cross‐species pattern. The two groups generally occupy non‐overlapping research circles, in terms of conferences and journals, and therefore interact little enough to largely avoid the need to reconcile their views, allowing the persistence of misconceptions in each field. Our goal is to identify and address the most important of these misconceptions and thereby make clear that both of these seemingly incongruent views contain valid points. We argue that two distinct but related traits have been lumped together under the same concept of “post‐reproductive lifespan,” one (post‐fertile viability) that is tremendously widespread and another (a post‐fertile life stage) that is derived to hominins, and that the differences and connections between these two traits are necessary for understanding human life‐history evolution.     

Unrepaired DNA damage facilitates elimination of uniparental chromosomes in interspecific hybrid cells

Elimination of uniparental chromosomes occurs frequently in interspecific hybrid cells. For example, human chromosomes are always eliminated during clone formation when human cells are fused with mouse cells. However, the underlying mechanisms are still elusive. Here, we show that the elimination of human chromosomes in human–mouse hybrid cells is accompanied by continued cell division at the presence of DNA damage on human chromosomes. Deficiency in DNA damage repair on human chromosomes occurs after cell fusion. Furthermore, increasing the level of DNA damage on human chromosomes by irradiation accelerates human chromosome loss in hybrid cells. Our results indicate that the elimination of human chromosomes in human–mouse hybrid cells results from unrepaired DNA damage on human chromosomes. We therefore provide a novel mechanism underlying chromosome instability which may facilitate the understanding of carcinogenesis.     

尼安德特人基因组学研究进展

尼安德特人是现代人最近的旁支,也是化石资料最丰富的古人类。在现代人起源问题的争论中,尼安德特人对现代人是否有遗传贡献是一个焦点问题。文章综述了近年来关于尼安德特人线粒体基因组和核基因组的研究进展,初步研究表明尼安德特人可能对现代人有遗传贡献,这引发了人们对现代人起源问题的重新思考。藉尼人基因组研究经验进行的古人类基因组学研究将有望揭开现代人起源的谜团,并丰富进化生物学相关领域的理论体系。     

Differential inactivation and separation of homologous and heterologous antiviral activity of human leukocyte interferon by a proteolytic enzyme.

Human leukocyte interferon (HuLeIF) can express its antiviral activity on both human and bovine cells. The rates of inactivation of HuLeIF by α-chymotrypsin, as expressed on human and bovine cells, are not the same: the ability to induce activity on human cells is lost significantly more rapidly than the activity detected on bovine cells; usually a margin of greater than one hundred-fold exists after α-chymotrypsin treatment. HuLeIF, when subjected to analysis on 10% SDS-PAGE, can be separated into two molecular weight species, one having apparent molecular weight of approximately 21,000 daltons, the other 18,000 daltons. A more rapidly migrating form (molecular weight 16,500 daltons) can also be isolated, which is considerably more active on bovine cells than on human cells. α-chymotrypsin-treated samples analyzed by SDS-PAGE show a clear separation of the activities expressed on human and bovine cells. The residual activity detected on human cells is isolated only in the 21,000 component while the activity found on bovine cells is recovered only as the 16,500 dalton species.